Infection Control and Disease Surveillance in Africa

By Crystal Lubbe

December 10, 2024

The topic of National borders as a critical frontline in containing deadly infections is increasingly significant for public health initiatives. The Africa CDC plays a crucial role in addressing infection prevention and control measures linked to these borders. Their approach emphasises the necessity of robust systems and collaborations that allow for effective management of health threats that cross national boundaries.

Infection Prevention and Control (IPC) Legal Framework

The Africa CDC has developed a comprehensive IPC Legal Framework aimed at strengthening infection prevention and control measures across African Union Member States. This framework incorporates six critical areas:
– Establishing national IPC programs
– Developing evidence-based guidance
– Training and educating personnel
– Conducting surveillance for healthcare-associated infections (HAIs)
– Developing systems to monitor compliance with laws
– Mandating specific staffing and infrastructure changes in hospitals.

Implementation and Support

The Africa CDC is actively assisting Member States in implementing this IPC Legal Framework through financial, technical, and collaborative support. Workshops and joint efforts with countries like Cameroon, Liberia, Malawi, and Nigeria have been conducted to review and enhance existing IPC programs and legal instruments.

Disease Surveillance and Health Security

In collaboration with the World Health Organization (WHO) and other partners, the Africa CDC has launched initiatives to strengthen disease surveillance and health security across Africa. This includes the Health Security Partnership designed to enhance integrated disease surveillance, event-based surveillance, genomic surveillance, and epidemic intelligence. Such partnerships are invaluable for swiftly detecting and addressing health security threats, especially since national borders serve as a critical frontline in containing deadly infections.

Cross-Border Disease Control

National borders are crucial in containing infections, making RISLNET vital. It harmonises labs, integrates surveillance, and boosts cross-border collaboration to combat regional health challenges.

Multi-Sectoral Collaboration

The Africa CDC promotes a multi-sectoral approach to align IPC measures with regional and international standards. This collaborative effort is crucial for effective implementation and fostering a healthier and safer environment across the continent.

In summary, the Africa CDC’s efforts in infection prevention and control, disease surveillance, and health security therefore, illustrate the vital role of National borders as a critical frontline in containing deadly infections. Their documented initiatives highlight the importance of robust legal frameworks, cross-border collaboration, and multi-sectoral approaches to effectively combat health threats.

Reference url

Recent Posts

oral health Africa
    

Oral Health in Africa: Promoting Collaborative Solutions

🦷 Is oral health taking a back seat in public health discussions in Africa?

A new article reveals alarming statistics about the high prevalence of untreated dental diseases across the continent and a critical shortage of oral health professionals. It emphasizes the urgent need for collaborative action among healthcare providers and policy-makers to integrate oral health into broader public health frameworks.

Discover how strengthening partnerships can pave the way for improved health outcomes and resource allocation in oral health.

#SyenzaNews #globalhealth #HealthEconomics

tislelizumab NSCLC treatment
        

Early Benefit Assessment of Tislelizumab NSCLC Treatment: Insights and Implications

🧐 How is the evolving treatment landscape for NSCLC affecting patient access to tislelizumab?

The German Federal Joint Committee (G-BA) has launched an early benefit assessment for tislelizumab as a second-line treatment for adults with advanced NSCLC. This assessment notably focuses on PD-L1 negative patients and highlights the need for additional data to substantiate its value amidst a shifting emphasis on first-line immunotherapy.

Explore the nuances of this assessment and its implications for future research and market access in the full article.

#SyenzaNews #oncology #MarketAccess

colorectal cancer screening
    

Advances in Colorectal Cancer Screening: Access and Cost

🚀 Is blood-based screening redefining colorectal cancer detection?

The Shield blood test offers a non-invasive alternative to colonoscopy—boosting screening uptake, but raising questions around effectiveness and value.

🔍 Discover how this innovation could reshape patient care, payer strategy, and health system costs.

#SyenzaNews #HealthcareInnovation #CostEffectiveness #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.